Screener
Mirum Pharmaceuticals, Inc. MIRM Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies | ||
| Stockholders’ (deficit) equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 64,754,699 and 51,896,391 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 6 | 5 |
| Additional paid-in capital | 1,515,172 | 981,878 |
| Accumulated deficit | (1,524,926) | (667,544) |
| Accumulated other comprehensive (loss) income | (674) | 351 |
| Total stockholders’ (deficit) equity | (10,422) | 314,690 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s common stock par value per share?
- Mirum Pharmaceuticals, Inc. (MIRM) reported common stock par value per share of $0.00 in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s common stock par value per share changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s common stock par value per share?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude